In 2008, responsibility for the Hyperbaric Oxygen Treatment (HBOT) facilities was transferred from Memorial Universitys Centre for Offshore and Remote Medicine (MEDICOR) to the Eastern Health Regional Health Authority. The transfer of services reflects an ongoing shift in the uses of HBOT from mainly being used as an emergency treatment and research tool toward being used for adjuvant treatments for non-emergent conditions.
Subsequently, Eastern Health partnered with the Contextualized Health Research Synthesis Program (CHRSP) to investigate what the scientific literature tells us about the evidence for the clinical and cost effectiveness of adjuvant HBOT for problem wounds.
In the context of this project, problem wounds include diabetic and non-diabetic pressure ulcers, delayed radiation-induced injury, thermal burns, skin grafts and flaps, and post-organ transplantation revascularization.
For this project, CHRSP has partnered with the Canadian Agency for Drugs and Technology in Health (CADTH) to identify and synthesize the recent high-level research literature, including systematic reviews, meta-analyses and health technology assessments. The synthesis also includes any high quality primary research that had been conducted recently enough so as not to have been captured by the review literature.